CP2C9 Polyclonal Antibody, 20ul Fluorescent Staining Acts as a negative regulator

Acts as a negative regulator of MAP3K3-mediated activation of ERK

May act as a protease inhibitor to modulate the host immune response against tumor cells

Experimental confirmation may be lacking for some isoforms|disease:Defects in ITGA6 are a cause of epidermolysis bullosa with pyloric atresia (EB-PA)

Mutations in this gene are associated with an autosomal dominant form of hereditary fibrosing poikiloderma (HFP)

CP2C9 Polyclonal Antibody, 20ul Fluorescent Staining Acts as a negative regulatorThis gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S warfarin. Studies